Even the most experienced eye care brands can stumble during supplier audits. From incomplete documentation to poor batch traceability, these findings can delay approvals or compromise product launches. This guide outlines the twelve issues most often flagged during audits for eye creams, serums, and drops—and how buyers can prevent them before inspection day.
1. Missing Product Information File (PIF)
Issue: Incomplete or unverified Product Information Files are one of the top compliance failures in EU and global audits.
- Prevention: Request a current, indexed PIF with all annexes (formula, safety assessment, stability, micro, label artwork).
- Evidence: Signed safety assessor report and updated raw material SDS.
2. Unverified Clinical or Efficacy Claims
Issue: Claims such as “reduces dark circles” or “ophthalmologist-tested” often lack traceable proof.
- Prevention: Ask for claim substantiation summaries and human patch/irritation studies.
- Evidence: Third-party study report or validated data summary.
3. Poor Batch Traceability
Issue: Inconsistent lot coding across bulk, fill, and label components undermines recall integrity.
- Prevention: Verify manufacturing batch coding system before production.
- Evidence: Traceability SOP and sample batch record showing code linkage.
4. Outdated Microbiological Testing
- Issue: Audit teams often find “one-time” micro validation without periodic re-tests.
- Prevention: Require micro test per batch or per year (ISO or USP compliant).
- Evidence: Micro certificate of analysis (COA) with test date and limits.
5. Preservative Efficacy Test (PET) Gaps
- Issue: PET reports missing challenge organism recovery data.
- Prevention: Check inclusion of reference strains (P. aeruginosa, S. aureus, C. albicans, A. brasiliensis).
- Evidence: Full PET report and approval sign-off by QA lead.
6. Misaligned Label Ingredients vs. Formula
- Issue: Label INCI list sometimes doesn’t match formula versions.
- Prevention: Align formula revision history with packaging artwork approval.
- Evidence: Final INCI validation form and approved label PDF.
7. Incomplete Stability Study
- Issue: Samples stored only under room temp conditions.
- Prevention: Request both accelerated (40°C, 75% RH) and long-term stability data.
- Evidence: Stability summary sheet covering color, odor, viscosity, pH, and microbiological results.
8. Inadequate Packaging Compatibility Testing
- Issue: Leakage, label wrinkling, or dropper degradation found post-fill.
- Prevention: Run compatibility checks for viscosity, light sensitivity, and preservative migration.
- Evidence: Compatibility test report with container material specs.
9. Supplier Qualification Gaps
- Issue: Raw material vendors without GMP or ISO certificates.
- Prevention: Pre-approve all sub-suppliers and retain certificates annually.
- Evidence: Vendor qualification form and audit certificate summary.
10. Incomplete Equipment Calibration Records
- Issue: Calibration logs missing traceability IDs.
- Prevention: Verify calibration status before production start.
- Evidence: Calibration certificate with next due date.
11. Insufficient Change Control Documentation
- Issue: Formula or packaging tweaks made without documented impact assessment.
- Prevention: Maintain a formal change control procedure.
- Evidence: Change approval record citing QA and regulatory review.
12. No Documented Training for Production Staff
- Issue: Employees working on ophthalmic lines lack verifiable GMP training records.
- Prevention: Require annual refresher training documentation.
- Evidence: Signed and dated training matrix with competencies noted.
Quick Reference Table: Most Frequent Eye Care Audit Findings
| # |
Finding |
Key Control |
Proof to Request |
| 1 |
Incomplete PIF |
Verification by safety assessor |
PIF + Annexes |
| 4 |
Outdated micro tests |
Batch COA updates |
Micro COA |
| 6 |
Label mismatch |
INCI alignment |
Approved label PDF |
| 8 |
Packaging leak |
Compatibility trial |
Packaging test report |
| 11 |
Uncontrolled changes |
Change control log |
QA Approval form |
Audit Preparation Tips
- Lock formula revisions before print artwork approval.
- Schedule pre-audit document reviews every 6 months.
- Digitize test and training logs—paper binders slow evidence retrieval.
- Ensure packaging compatibility tests include time-lapse observations (2–4 weeks minimum).
FAQ
How often should micro testing be repeated for eye care products?
At least once per production batch or annually, depending on stability data and product sensitivity.
Do all eye creams need ophthalmologist testing?
Not legally mandatory, but recommended for claims and consumer trust—request third-party lab validation where possible.
How long should a complete stability study last?
Standard test plans run 3–12 months, aligning accelerated and real-time conditions for accurate shelf life prediction.
Can packaging compatibility tests be simulated?
Initial screenings can be simulated, but final validation requires filled product tests to account for real interaction.
Who should maintain the PIF?
The brand owner is formally responsible, but manufacturers should provide all data modules and keep copies under confidentiality.
Request a Quote to review your supplier readiness and get compliant formulation support for eye care production.
Hi, I'm Alex Zong, hope you like this blog post.
With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.
